drugset / Trial / NCT01633749

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season

NCT01633749

Phase 3 Completed 120 enrolled Abbott Biologicals
NaSingle-groupOpen-label

Summary

Annual study to investigate influenza vaccine (flu vaccine) developed for the 2012/2013 season for the prevention of influenza infection. The immunizing effect is being investigated, as well as its tolerability and safety.

Timeline

Start
2012-07
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine 15 ug
Subject Influenza Virus Vaccine Vaccine 0.5 ml

Indications

No indication recorded.